172 related articles for article (PubMed ID: 31756181)
1. Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.
Piazzese C; Foley K; Whybra P; Hurt C; Crosby T; Spezi E
PLoS One; 2019; 14(11):e0225550. PubMed ID: 31756181
[TBL] [Abstract][Full Text] [Related]
2. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
3. Comparison of radiomic features in diagnostic CT images with and without contrast enhancement in the delayed phase for NSCLC patients.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Hirashima H; Matsuo Y; Mizowaki T
Phys Med; 2020 Jan; 69():176-182. PubMed ID: 31918370
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.
Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L
Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Overall Survival and Progression-Free Survival by the
Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
[No Abstract] [Full Text] [Related]
6. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
Foley KG; Fielding P; Lewis WG; Karran A; Chan D; Blake P; Roberts SA
Eur J Radiol; 2014 Jul; 83(7):1069-1073. PubMed ID: 24794862
[TBL] [Abstract][Full Text] [Related]
8. Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer.
Mostafa R; Abdelsamie Kandeel A; Abd Elkareem M; Nardo L; Abdelhafez YG
Nucl Med Commun; 2022 May; 43(5):540-548. PubMed ID: 35190518
[TBL] [Abstract][Full Text] [Related]
9. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
10. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of CT radiomic features combined with clinical factors in predicting prognosis in patients with limited-stage small cell lung cancer.
Wu J; Zhou Y; Xu C; Yang C; Liu B; Zhao L; Song J; Wang W; Yang Y; Liu N
BMC Cancer; 2024 Feb; 24(1):170. PubMed ID: 38310283
[TBL] [Abstract][Full Text] [Related]
12. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
Huynh E; Coroller TP; Narayan V; Agrawal V; Romano J; Franco I; Parmar C; Hou Y; Mak RH; Aerts HJ
PLoS One; 2017; 12(1):e0169172. PubMed ID: 28046060
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography-based radiomic markers are independent prognosticators of survival in advanced laryngeal cancer: a pilot study.
Rajgor AD; Kui C; McQueen A; Cowley J; Gillespie C; Mill A; Rushton S; Obara B; Bigirumurame T; Kallas K; O'Hara J; Aboagye E; Hamilton DW
J Laryngol Otol; 2024 Jun; 138(6):685-691. PubMed ID: 38095096
[TBL] [Abstract][Full Text] [Related]
14. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.
Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW
Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced CT-based Textural Parameters as Potential Prognostic Factors of Survival for Colorectal Cancer Patients Receiving Targeted Therapy.
Zhao Y; Yang J; Luo M; Yang Y; Guo X; Zhang T; Hao J; Yao Y; Ma X
Mol Imaging Biol; 2021 Jun; 23(3):427-435. PubMed ID: 33108800
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer.
Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P
Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421
[TBL] [Abstract][Full Text] [Related]
17. Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months.
Rizzo S; Botta F; Raimondi S; Origgi D; Buscarino V; Colarieti A; Tomao F; Aletti G; Zanagnolo V; Del Grande M; Colombo N; Bellomi M
Eur Radiol; 2018 Nov; 28(11):4849-4859. PubMed ID: 29737390
[TBL] [Abstract][Full Text] [Related]
18. Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy.
Zeng C; Zhai T; Chen J; Guo L; Huang B; Guo H; Liu G; Zhuang T; Liu W; Luo T; Wu Y; Peng G; Li D; Chen C
Radiat Oncol; 2021 Jan; 16(1):8. PubMed ID: 33436018
[TBL] [Abstract][Full Text] [Related]
19. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
[TBL] [Abstract][Full Text] [Related]
20. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
Brown PJ; Zhong J; Frood R; Currie S; Gilbert A; Appelt AL; Sebag-Montefiore D; Scarsbrook A
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2790-2799. PubMed ID: 31482428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
